To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min C. diff is the leading cause of ...

ATLANTA -- Mortality rates from Clostridioides difficile-related infections have fallen steadily since 2016, but the condition continues to take an uneven lethal toll based on sex, demographics, and ...

As the effectiveness of antibiotics meant to fight the deadly superbug Clostridioides difficile, or C. diff, wanes, a research team at the University of Houston is seeing positive results of a new ...

Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...

A nephrology unit at Detroit-based Henry Ford Hospital has lowered Clostridioides difficile infections by 90% since 2023. Leaders at the hospital credit the progress to the Comprehensive Unit-based ...

The bacterium Clostridium difficile — otherwise known as C. diff — spreads within intensive care units more than three times as much as previously thought, according to a study published on April 4 in ...

One of the most common health care-associated infections spreads within intensive care units (ICUs) more than three times more than previously thought, new research has found. IMPACT: The results ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Signs of inflammatory bowel disease (IBD) activity, shorter duration of IBD, and previous corticosteroid use and hospitalisation were associated with Clostridioides difficile infection in patients ...

FDA approved to prevent recurrent C. difficile infection (rCDI), REBYOTA is widely available with a strong drug supply and dedicated manufacturing facility Since launch, Ferring created REBYOTA @ Home ...